MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sucampo Pharmaceuticals Company Profile (NASDAQ:SCMP)

Consensus Ratings for Sucampo Pharmaceuticals (NASDAQ:SCMP) (?)
Ratings Breakdown: 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $21.88 (76.13% upside)

Analysts' Ratings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016WallachBeth CapitalUpgradeHold -> Buy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016MizuhoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016GuggenheimReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2016Maxim GroupReiterated RatingBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016Leerink SwannReiterated RatingMarket Perform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016Jefferies GroupLower Price TargetHold$19.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015HC WainwrightLower Price Target$36.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Cantor FitzgeraldDowngradeBuy -> Hold$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Credit SuisseDowngradeNeutral -> Underperform$10.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha